Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Melatonin- and Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects In Vitro and Neuroprotective Effects in a Pharmacological Alzheimer’s Disease Mouse Model
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 7, Pages 3794-3812
Publisher
American Chemical Society (ACS)
Online
2021-03-27
DOI
10.1021/acs.jmedchem.0c01940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tacrine-hydroxamate Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, and Biological Evaluation
- (2020) Ana Xu et al. BIOORGANIC CHEMISTRY
- Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease
- (2020) Hui-Ju Tseng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease
- (2020) Mazel Mihardja et al. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
- Two-hit wonders: The expanding universe of multitargeting epigenetic agents
- (2020) Angel R. de Lera et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer’s disease
- (2020) Feng He et al. BIOORGANIC CHEMISTRY
- Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer’s Disease
- (2020) Simon Couly et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
- (2020) Joshua P. Smalley et al. MOLECULES
- Harnessing Polypharmacology with Medicinal Chemistry
- (2019) Maria Laura Bolognesi ACS Medicinal Chemistry Letters
- Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease
- (2019) Angela De Simone et al. ACS Medicinal Chemistry Letters
- Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
- (2019) Angela De Simone et al. ChemMedChem
- Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
- (2019) Junting Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metal Ions in Alzheimer’s Disease: A Key Role or Not?
- (2019) Yan Liu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Epigenetic polypharmacology: A new frontier for epi-drug discovery
- (2019) Daniela Tomaselli et al. MEDICINAL RESEARCH REVIEWS
- Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
- (2019) Obdulia Rabal et al. ACS Chemical Neuroscience
- Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
- (2019) Margherita Brindisi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
- (2019) Matthias Scheiner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer’s Disease Mouse Model
- (2019) Matthias Hoffmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- 7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in vivo
- (2019) Sandra Gunesch et al. Redox Biology
- A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
- (2019) Sida Shen et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6
- (2019) Jeremy D. Osko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors
- (2018) Irina N. Gaisina et al. ACS Chemical Neuroscience
- A simple, cheap but reliable method for evaluation of zinc chelating properties
- (2018) Maria Carmen Catapano et al. BIOORGANIC CHEMISTRY
- Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status
- (2018) Xiaoyang Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
- (2018) Hsueh-Yun Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Complex neuroprotective and neurotoxic effects of histone deacetylases
- (2018) Elizabeth A. Thomas et al. JOURNAL OF NEUROCHEMISTRY
- The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model
- (2018) Sheng-Jun Fan et al. Cell Death & Disease
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity
- (2018) Nicholas J. Porter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ferulic acid promotes survival and differentiation of neural stem cells to prevent gentamicin-induced neuronal hearing loss
- (2017) Lintao Gu et al. EXPERIMENTAL CELL RESEARCH
- High-throughput assay comparison and standardization for metal chelating capacity screening: A proposal and application
- (2017) Jânio Sousa Santos et al. FOOD CHEMISTRY
- Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups
- (2017) Viktoria Krieger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
- (2017) Nicholas J. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design, synthesis, and preliminary bioactivity evaluation of N 1 -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors
- (2016) Xue Wang et al. Chemical Biology & Drug Design
- Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors
- (2016) D. Diedrich et al. CHEMICAL COMMUNICATIONS
- Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
- (2016) Obdulia Rabal et al. JOURNAL OF MEDICINAL CHEMISTRY
- A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
- (2016) Mar Cuadrado-Tejedor et al. NEUROPSYCHOPHARMACOLOGY
- Ferulic Acid and Alzheimer’s Disease: Promises and Pitfalls
- (2015) Seyed Nabavi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Histone deacetylases in memory and cognition
- (2014) J. Penney et al. Science Signaling
- Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors
- (2013) Fang Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Glutathione and thioredoxin dependent systems in neurodegenerative disease: What can be learned from reverse genetics in mice
- (2013) Marcus Conrad et al. NEUROCHEMISTRY INTERNATIONAL
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Selective Histone Deacetylase 6 Inhibitors Bearing Substituted Urea Linkers Inhibit Melanoma Cell Growth
- (2012) Joel A. Bergman et al. JOURNAL OF MEDICINAL CHEMISTRY
- DSX: A Knowledge-Based Scoring Function for the Assessment of Protein–Ligand Complexes
- (2011) Gerd Neudert et al. Journal of Chemical Information and Modeling
- Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
- (2010) James A. Duce et al. PROGRESS IN NEUROBIOLOGY
- Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors
- (2008) David V. Smil et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Peptoid architectures: elaboration, actuation, and application
- (2008) Barney Yoo et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- DPPH antioxidant assay revisited
- (2008) Om P. Sharma et al. FOOD CHEMISTRY
- Histone deacetylase 6 interacts with the microtubule-associated protein tau
- (2008) Huiping Ding et al. JOURNAL OF NEUROCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started